Fundraising Fox
/Companies
Sign in

Graphtx

Vienna, AT · Founded 2024 · 14 employees on LinkedIn · 4 known investors

Find your way into Graphtx

Sign up to see every warm intro you have to Graphtx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Graphtx team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

GraphTx is an AI-driven platform for drug discovery that validates immunology and inflammation drug targets using live patient samples before clinical trials. The company serves pharmaceutical researchers by applying machine learning to patient immune cell data to reduce development risk and failure rates.

AI & Machine LearningBiotechDigital Health

Investors · 4

SquareOnelisted by SquareOneBerlin · $378K – $3.8M

How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Transpose Platform Managementlisted by Transpose Platform ManagementSan Francisco

How we know: Transpose Platform Management's portfolio page · Not right? Tell us

Merantix CapitalreportedBerlin · $540K – $4.3M

How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Related companies · 2

RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
AmetrisAmetris provides sensor-based digital measures and digital endpoints for clinical trials, capturing data from wearable sensors and real-world patient insights. Now part of Signant Health, it supports clinical trial sponsors running decentralized, hybrid, and traditional studies alongside electronic Clinical Outcome Assessment (eCOA) capabilities.

Companies working in the same space as Graphtx.

Frequently asked questions

What does Graphtx do?
GraphTx is an AI-driven platform for drug discovery that validates immunology and inflammation drug targets using live patient samples before clinical trials. The company serves pharmaceutical researchers by applying machine learning to patient immune cell data to reduce development risk and failure rates.
Who are Graphtx's investors?
Graphtx's investors include Daphni, SquareOne, Transpose Platform Management, Merantix Capital.
Where is Graphtx headquartered?
Graphtx is headquartered in Vienna, AT.